Swiss firm Datwyler to expand sealing facility in Maharashtra

Datwyler - the Switzerland-based global supplier of customised sealing solutions to manufacturers and companies which operate in the healthcare, automotive, civil engineering and consumer goods sectors – will construct its most advanced manufacturing facility - FirstLine - at the Datwyler India’s Satara site in Maharashtra. The FirstLine facility, to be integrated in the existing premise, will be fully operational in 2017. The most complex rubber components produced at the FirstLine site belong to the Omniflex family of vial and syringe components, which prevent any interaction with the drugs due to their total fluoropolymer coating. These components are exclusively manufactured at the FirstLine sites.
 
Omniflex, a Datwyler proprietary process, is an inert, flexible, fluorinated polymer coating for pharmaceutical rubber closures, which covers the entire product surface. The chemical inertness of the fluorinated polymer coating provides a very high degree of compatibility with pharmaceutical or biotechnology products. Datwyler India will supply the products made in the FirstLine production facility in Satara to the company’s customers worldwide.

 
Rahul Dev, vice president, Datwyler India, said, “Datwyler’s latest investment in India through the commencement of the FirstLine facility in Satara is part of the company’s commitment to India and the Asian markets. Present in India since 2010, Datwyler is dedicated to guaranteeing the highest levels of quality and safety, and continues to make investments aimed at meeting global regulatory requirements. The plant currently employs 290 people. It will employ 350 people by the time the production starts in 2017.”
 
India’s pharmaceutical and biotech markets are evolving rapidly and have been able to gain traction from global manufacturers, suppliers and customers. The country is also getting recognised as one of the global manufacturing destinations. “Our new FirstLine facility in Satara makes a great business case for us as we look at catering to global markets. Datwyler is one of the leading producers of closure solutions for injectable and vial medicines. The company’s products are supplied to the world’s leading pharmaceutical and biotechnology companies to support their efforts towards save and effective drug delivery for a healthier world,” added Dev.

ALSO READ: Italy's IMA to enhance packaging machinery exports from Hassia India
 
The healthcare unit of the Datwyler Sealing Solutions division designs, develops and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment. In addition to the Omniflex series, vial stoppers of different sizes as well as plunger stoppers will be produced in this FirstLine facility.
 
The Datwyler Group offers a range of specialised and unique coatings, elastomer formulations, and aluminium seals that allow customers to effectively package and administer drug products in the most efficient manner. Datwyler’s products are supplied to the world’s leading pharmaceutical and biotechnology companies to support their efforts towards safe and effective drug delivery for a healthier world. With a global manufacturing footprint on three continents and sales in over 100 countries, the Datwyler Sealing Solutions division generates an annual revenue in excess of Euro 500 million.